Search clinical trials for: Luteolytic Agents

Total 188104 results

Debiopharm International SA
Quintiles, Inc.

Completed

Study on Efficacy, Pharmacokinetics, and Safety of Two Subcutaneous Injections of Triptorelin Embonate 6 Month Formulation in Patients With Advanced Prostate Cancer

Prostate Cancer

South Africa
Sheffield Teaching Hospitals NHS Foundation Trust
Ipsen

Completed

Decapeptyl SR With Livial Add Back Therapy in the Management of Chronic Cyclical Pelvic Pain in Pre Menopausal Women

Endometriosis

United Kingdom
Ipsen

Completed

Efficacy and Safety Study of Pamoate of Triptorelin in Children With Precocious Puberty (DECAPUB)

Precocious Puberty

France
Vietnam National University
Merck Sharp & Dohme LLC; Aarhus University Hospital; University of Southern Denmark and other collaborators

Completed

GnRHa Trigger in Asian Oocyte Donors- a Dose Finding Study

Normal Oocyte Donors

Vietnam
Masaryk University
Ministry of Health, Czech Republic

Completed

Prevention of Ovarian Function Damage by a GnRH Analogue During Chemotherapy in Hodgkin Lymphoma Patients (OVARONKO)

Hodgkin Disease | Hodgkin Lymphoma

Czech Republic
Universitair Ziekenhuis Brussel

Completed

Corifollitropin Alfa Followed by hpHMG in a Long GnRH Agonist Protocol for the Treatment of Poor Ovarian Responders

Infertility | Poor Ovarian Response

Belgium
Sir Mortimer B. Davis - Jewish General Hospital

Not yet recruiting

The Predictive Value of TMPRSS2-ERG Fusion in High Risk Prostate Cancer Patient

Prostate Cancer
Ipsen

Completed

Equivalence of Intramuscular (IM) Versus Subcutaneous (SC) Applications of Long Acting Pamorelin 11.25 mg (PAMIS)

Prostate Cancer

Germany
Ipsen

Completed

A Study to Describe the Efficacy of Diphereline Following Conservative Surgery in Deep Infiltrating Endometriosis (DIE) Patients Over a Period of 24 Months (DIE-NIS)

Deep Infiltrating Endometriosis (DIE)

China
UNICANCER
Ipsen

Active, not recruiting

Triptorelin and Radiation Therapy in Treating Patients Who Have Undergone Surgery for Intermediate-Risk Stage III or Stage IV Prostate Cancer

Prostate Cancer

France
Aristotle University Of Thessaloniki
Eugonia IVF Unit, Athens, Greece

Unknown

Evaluation of the Optimal Dose of GnRH Agonist for Triggering Final Oocyte Maturation in High Risk OHSS Patients (ATD)

Subfertility

Greece
AZ Jan Palfijn Gent
Onze Lieve Vrouw Hospital

Completed

Trial Comparing hCG Triggering Versus hCG Associated With GnRH Agonist

Infertility

Belgium
University of Illinois at Chicago
National Institute on Aging (NIA)

Recruiting

Aging and Mixed Perturbation Training to Reduce Falls in Locomotion

Older Adults

United States
Children's Hospital Medical Center, Cincinnati
Watson Pharmaceuticals

Completed

Triptorelin for Ovary Protection in Childhood Onset Lupus

Systemic Lupus Erythematosus

United States, Brazil
Sheba Medical Center

Completed

Follicle Size and Oocyte Development (AMJH)

IVF Treatment

Israel
Mansoura University

Completed

HCG Levels After Ovulation Triggering as Predictors of ICSI Outcome

Infertility

Egypt
Kasr El Aini Hospital

Completed

Effect of Prolonged GnRh Agonists on Results of Intracytoplasmic Sperm Injection (ICSI ) in Endometrioma Patients (GnRh)

Endometrioma

Egypt
Universitair Ziekenhuis Brussel
Universitaire Ziekenhuizen KU Leuven

Recruiting

DEPO-Trigger Trial: GnRH Agonist DEPOt TRIGGER for Final Oocyte Maturation (Depo-Trigger)

Breast Cancer Female

Belgium
Watson Pharmaceuticals

Completed

Randomized Crossover Trial to Assess the Tolerability of Gonadotropin Releasing Hormone (GnRH) Analogue Administration

Prostate Cancer

United States
Instituto de Investigación en Oncología Radioterápica...

Recruiting

Short Versus Long-term Androgen Deprivation Therapy With Salvage Radiotherapy in Prostate Cancer. URONCOR 0624 (URONCOR 06-24)

Prostate Cancer | Biochemical Recurrence | Androgen Deprivation Therapy | Salvage Radiotherapy | Metastases-free Survival

Spain
Instituto de Investigacion Sanitaria La Fe

Completed

Evaluation of Time Interval Between Ovulation Trigger With Triptorelin Acetate and Oocyte Retrieval (TIMING)

Female Urogenital Diseases

Spain
Ipsen

Completed

Study To Assess Renewal Of Treatment In Patients Recently Diagnosed With Prostate Cancer (CHRONOS3)

Prostate Cancer

Romania
Miao benyu

Unknown

Effects of SNP of GnRH Receptor Genes in IVF Patients

Infertility, Female
Tehran University of Medical Sciences

Completed

Half-Dose Depot Triptorelin Versus Reduced-Dose Daily Buserelin

Infertility

Iran, Islamic Republic of
Aragon Pharmaceuticals, Inc.

Completed

The Role of Highly Selective Androgen Receptor (AR) Targeted Therapy in Men With Biochemically Relapsed Hormone Sensitive Prostate Cancer

Prostate Cancer

United States
Ain Shams University

Completed

Agonist Trigger With HCG Luteal Supplementation vs HCG Trigger With Progesterone Luteal Supplementation in Antagonist Controlled HyperstimulationCycle

Infertility, Female

Egypt
American University of Beirut Medical Center

Completed

Dual Trigger in the Final Oocyte Maturation in Poor Ovarian Responders

Poor Ovarian Reserve

Lebanon
Alcon Research

Withdrawn

Safety and Efficacy Study of DuoTrav APS Versus DuoTrav

Ocular Hypertension | Open-angle Glaucoma
St. Luke's Hospital, Ireland

Unknown

Combination Hormone Therapy Followed by Radiation Therapy in Treating Patients With Prostate Cancer

Prostate Cancer

Ireland, United Kingdom
Pharmatech
Watson Pharmaceuticals; Manyak, Michael, M.D.

Terminated

Comparison of Trelstar Versus Lupron or Zoladex in Advanced Prostate Cancer

Prostate Cancer

United States
UNICANCER

Completed

Triptorelin, Flutamide, and External-Beam Radiation Therapy or External-Beam Radiation Therapy Alone in Treating Patients With Stage II or Stage III Prostate Cancer

Prostate Cancer

France
IVI Madrid

Completed

Dual Triggering in Patients With a High Immature Oocyte Rate

INFERTILITY
Erasme University Hospital
Ipsen; Fonds National de la Recherche Scientifique

Completed

Efficiency of Gonadotropin-releasing Hormone (GnRH) Agonist in Preventing Chemotherapy Induced Ovarian Failure (Erasme-POF)

Lymphoma | Fertility Preservation | Alkylating Agents

Belgium, France, Italy
Bart CJM Fauser

Terminated

A Study of the Effects of a Novel Ovarian Stimulation Regimen on Embryo Aneuploidy Rates in In Vitro Fertilization (IVF)

In Vitro Fertilization

Netherlands
Cairo University

Unknown

Accuracy of Ultrasound Markers Versus Biochemical Markers in Prediction of Ovarian Response in Obese Women Undergoing IVF/ICSI Treatment

Invitro Fertilization

Egypt
Sheba Medical Center

Unknown

Modified Luteal Support for Frozen-Thawed Embryo Transfer - A Prospective Study

Embryo Transfer | Luteal Support

Israel
Fertility - Assisted Fertilization Center

Completed

Ovarian Stimulation Using Recombinant Follicle-stimulating Hormone (FSH) and Gonadotrophin Releasing Hormone (GnRH) Agonist in Alternate Days (Gonapeptyl)

Infertility

Brazil
Organon and Co

Completed

A Study to Assess the Efficacy and Safety of Ganirelix (Orgalutran®) Treatment in Chinese Women Undergoing Controlled Ovarian Stimulation for in Vitro Fertilization (IVF) or Intra Cytoplasmatic Sperm Injection (ICSI) (Study 38651)(P05703)

Controlled Ovarian Stimulation
V.K.V. American Hospital, Istanbul

Completed

GnRH Agonist Administration in the Luteal Phase of ICSI-ET Cycles

Infertility

Turkey
Sheffield Teaching Hospitals NHS Foundation Trust
HRA Pharma

Completed

Glucocorticoid Receptor Antagonism in Subclinical Cushings

Subclinical Cushing's

United Kingdom
Mediterranea Medica S. L.

Completed

Mifepristone 10 or 5 mg for 6 Months to Treat Uterine Fibroids (Mifemyo_2)

Uterine Fibroids

Cuba
Corcept Therapeutics

Completed

A United States Extension Study of Corlux for Recurrent Psychotic Symptoms in Psychotic Major Depression

Depressive Disorder, Major

United States
Corcept Therapeutics
Institute for the Study of Aging (ISOA)

Terminated

Mifepristone as Adjunctive Therapy in Alzheimer's Disease

Alzheimer's Disease

United States
Karolinska Institutet

Completed

BRCA1/2 and Effect of Mifepristone on the Breast

Women With Mutations in the Breast Cancer Susceptibility Genes BRCA1,2

Sweden
Corcept Therapeutics

Completed

An International Extension Study of Corlux for Recurrent Psychotic Symptoms in Psychotic Major Depression

Psychotic Disorders | Major Depressive Disorder

Bulgaria, Croatia, Romania, Serbia
Alexandria University

Completed

Addition of Gonadotropin Releasing Hormone Agonist to Luteal Phase Support

Female Infertility

Egypt
Ipsen

Completed

Study to Compare the Oestradiol Suppression, Clinical Efficacy and Safety of Two Formulations of Triptorelin (Triptorelin Pamoate PR 3-month and Triptorelin Acetate PR 1-month) in Chinese Subjects With Endometriosis

Endometriosis

China
Ipsen

Terminated

GP Extended Action Triptorelin (GREAT)

Prostate Cancer

United Kingdom
Marco Lorenzo Bonu
Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia

Recruiting

SRT Versus SRT+ADT in Prostate Cancer (SPA)

Prostate Cancer

Italy
The University of Hong Kong

Recruiting

GnRH Agonist for Dual Trigger in IVF and for Luteal Phase Support in FET

Subfertility

China

3

Subscribe